ClinicalTrials.gov
public full text
Public Domain
Post-Marketing Surveillance Study of OTEZLA
To evaluate the safety and efficacy of OTEZLA in actual clinical settings of use in patients with Psoriasis vulgaris that is with an inadequate response to topical therapies and Psoriasis arthropathica 1. Planned registration period 2 years 2. Planned surveillance period for 4 years from 6 months after launch
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Korean Regulatory Post Marketing Surveillance for Somavert#837412
- Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets#981570
- Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea#1103263
- Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO#969702
- Impacto de las estrategias de marketing basadas en influencers en la decisión de compra de productos de la industria cosmética#190510
Record · ID 803096
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive